Read More

On Jan 17, Aveo Oncology’s Lg Chem Received Written Notice From CFIUS That There Were No Unresolved National Security Concerns Regarding Transaction; All Required Regulatory Approvals To Complete Merger Have Now Been Received

As previously disclosed, on October 18, 2022, AVEO Pharmaceuticals, Inc., a Delaware corporation (“AVEO”), entered into an Agreement and Plan of Merger (the “Merger Agreement”) with LG Chem,

AVEO

Read More

Reported Late Thursday, AVEO Oncology Stockholders Approve Acquisition By LG Chem; AVEO Stockholders Will Receive $15.00 Per Share In Cash Upon The Closing Of The Transaction

AVEO Oncology ("AVEO") (NASDAQ:AVEO), a commercial stage, oncology-focused biopharmaceutical company committed to delivering medicines that provide a better life for patients with cancer, announced that at a special meeting of stockholders (the "Special Meeting") held today, AVEO stockholders approved th

AVEO

Read More

US Stock Futures Lower Following Friday’s Rally; Tesla In Focus

Pre-open movers U.S. stock futures traded lower in early pre-market trade on Monday after recording sharp gains in the previous session. The Dow Jones jumped by around 750 points on Friday. All the three major indices recorded their best week since June, with the S&P 500 and Dow adding 4.7% and 4.9%, respectively last week.

AVEO